Harish Poojary murder: Another Bajrang Dal activist nabbed from Gujarat

Mangaluru, Jul 21: Private hospitals cannot send back COVID-19 patients for any reason, district in-charge minister Kota Srinivas Poojary said on Monday.

The Minister was addressing a meeting at the Father Muller Medical College here on the arrangements made for COVID-19 patients.

Dakshina Kannada district is quite advanced in the medical field. Hence, the government will not tolerate COVID-19 patients wandering from one hospital to another for treatment. Refusing to admit COVID-19 patients in hospitals is unacceptable, he warned.

Bengaluru, Jun 25: State-run Kumara Krupa Guest House in the city will be used as 100-bed COVID-19 treatment center for the designated category patients, Karnataka Health Department Sources said here on Thursday.

According to official sources, one wing of the Guest House with 100-bed rooms of individual occupancy having all the facilities is reserved to work as Covid Care Center (CCC) and it will be used for Ministers, MPs, MLAs/MLCs, Senior officers of above Secretary rank for clinical management.

The total number of positive cases reported till date in the State has increased to 10,118, the sources added.

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.